Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The genomic and transcriptional landscape of primary central nervous system lymphoma. | Nat Commun | 2022 | 35538064 | PubTator, text mining | PubMed |
| The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions. | Curr Res Immunol | 2022 | 35496822 | PubTator, text mining | PubMed |
| Shared acute phase traits in effector and memory human CD8 T cells. | Curr Res Immunol | 2022 | 35496820 | PubTator, text mining | PubMed |
| [Epigenetic modification as a therapeutic approach for B-cell lymphoma]. | Rinsho Ketsueki | 2022 | 35491222 | PubTator, text mining | PubMed |
| Proteomic networks associated with tumor-educated macrophage polarization and cytotoxicity potentiated by heat-killed tuberculosis. | Sci Rep | 2022 | 35477732 | PubTator, text mining | PubMed |
| Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells. | Cell Rep | 2022 | 35476984 | PubTator, text mining | PubMed |
| Haploidentical transplantation has a superior graft-versus-leukemia effect than HLA-matched sibling transplantation for Ph- high-risk B-cell acute lymphoblastic leukemia. | Chin Med J (Engl) | 2022 | 35467818 | PubTator, text mining | PubMed |
| Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells. | Front Immunol | 2022 | 35464486 | PubTator, text mining | PubMed |
| Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How? | J Pers Med | 2022 | 35455658 | PubTator, text mining | PubMed |
| Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach. | Cancers (Basel) | 2022 | 35454765 | PubTator, text mining | PubMed |
| Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling. | PLoS One | 2022 | 35452489 | PubTator, text mining | PubMed |
| Beyond Wrapping: Canonical and Noncanonical Functions of Schwann Cells. | Annu Rev Neurosci | 2022 | 35440141 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer. | Front Cell Dev Biol | 2022 | 35433686 | PubTator, text mining | PubMed |
| Hyper-Methylated Hub Genes of T-Cell Receptor Signaling Predict a Poor Clinical Outcome in Lung Adenocarcinoma. | J Oncol | 2022 | 35432532 | PubTator, text mining | PubMed |
| Cancer stem-like cells evade CD8+CD103+ tumor-resident memory T (TRM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model. | J Immunother Cancer | 2022 | 35418483 | PubTator, text mining | PubMed |
| Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma. | Haematologica | 2022 | 35417939 | PubTator, text mining | PubMed |
| The use of oncolytic virotherapy in the neoadjuvant setting. | J Immunother Cancer | 2022 | 35414592 | PubTator, text mining | PubMed |
| Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia. | Nat Commun | 2022 | 35411050 | PubTator, text mining | PubMed |
| Modified eQTL and Somatic DNA Segment Alterations in Esophageal Squamous Cell Carcinoma for Genes Related to Immunity, DNA Repair, and Inflammation. | Cancers (Basel) | 2022 | 35406404 | PubTator, text mining | PubMed |
| Cellular Interaction Analysis Characterizing Immunosuppressive Microenvironment Functions in MM Tumorigenesis From Precursor Stages. | Front Genet | 2022 | 35401705 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=31